Proteomics International Laboratories Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was AUD 6.18 million compared to AUD 4.97 million a year ago. Basic loss per share from continuing operations was AUD 0.05 compared to AUD 0.05 a year ago.
Proteomics International Laboratories Limited
Equities
PIQ
AU000000PIQ0
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.095 AUD | +0.46% | +0.46% | +22.35% |
Mar. 25 | Proteomics International Signs Agreement with University of Oxford for Endometriosis Study | MT |
Mar. 19 | Proteomics Says PromarkerD's US Launch Delayed | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.35% | 93.47M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PIQ Stock
- News Proteomics International Laboratories Limited
- Proteomics International Laboratories Limited Reports Earnings Results for the Full Year Ended June 30, 2023